Background: Frailty and body mass index (BMI) are known to be predictive of late life mortality, but little is known about the combined effects of frailty and BMI on mortality. Objective: This study investigated the influence of frailty status and BMI category on mortality in older adults. Methods: Data were from the Living Profiles of Older People Survey, a national survey of community-dwelling older people in Korea, with a baseline study of 11,844 Koreans aged 65 years and older in 2008 and a 3-year follow-up for mortality. Frailty was categorized as not frail, prefrail, and frail, based on five indicators (weight loss, exhaustion, physical activity, walking speed, and grip strength). BMI (kg/m2) was classified as underweight (<18.5), normal (18.5-24.9), overweight (25.0-29.9), or obese (≥30.0). A Cox proportional model was used to analyze the association of the combined frailty and BMI categories with all-cause mortality, adjusting for sociodemographics and health-related factors. Results: Adjusting for covariates, compared with the normal-weight nonfrail counterpart, the underweight or normal-weight prefrail/frail status demonstrated significantly increased rates of death. The obese frail respondents showed a significantly higher mortality risk (hazard ratio, 3.89; 95% confidence interval, 1.14-13.28). The overweight prefrail/frail group, however, exhibited no significant association with mortality. Conclusion: Among older people who were of normal weight or underweight, greater frailty was associated with poorer survival. Whereas being overweight tended to be neutral of the influence of frailty on mortality, the obese frail exhibited a significantly elevated rate of death.

Keywords:
Frailty, Body mass index, Mortality, Older people
1.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K: Frailty in elderly people. Lancet 2013;381:752-762.
2.
Collard RM, Boter H, Schoevers RA, Oude Voshaar RC: Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012;60:1487-1492.
3.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M157.
4.
Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM; for the Study of Osteoporotic Fractures Research Group: Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007;62:744-751.
5.
Shamliyan T, Talley KMC, Ramakrishnan R, Kane RL: Association of frailty with survival: a systematic literature review. Ageing Res Rev 2013;12:719-736.
6.
Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, Fantin F, Bissoli L, Bosello O: Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes Relat Metab Disord 2005;29:1011-1029.
7.
Dorner TE, Rieder A: Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 2012;155:56-65.
8.
DeCaria JE, Sharp C, Petrella RJ: Scoping review report: obesity in older adults. Int J Obes 2012;36:1141-1150.
9.
Bowen ME: The relationship between body weight, frailty, and the disablement process. J Gerontol B Psychol Sci Soc Sci 2012;67:618-626.
10.
Prado CMM, Wells JCK, Smith SR, Stephan BCM, Siervo M: Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012;31:583-601.
11.
Rolland Y, Van Kan GA, Gillette-Guyonnet S, Vellas B: Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 2011;14:15.
12.
Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-567.
13.
Asia Pacific Cohort Studies Collaboration: The burden of overweight and obesity in the Asia-Pacific region. Obes Rev 2007;8:191-196.
14.
Villareal DT, Apovian CM, Kushner RF, Klein S: Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 2005;13:1849-1863.
15.
Roubenoff R: Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004;12:887-888.
16.
Keimyung University Industry-Academic Cooperation Foundation: 2008 Living Profiles of Older People Survey: a national report on the living status and welfare needs of older adults. Seoul, Ministry of Health and Welfare, Keimyung University Industry-Academic Cooperation Foundation, 2009.
17.
WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
18.
Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Youn JC, Kim SY, Woo SI, Woo JI: A normative study of the Mini-Mental State Examination in the Korean elderly. J Korean Neuropsychiatr Assoc 2002;41:508-525.
19.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20.
World Health Organization, World Bank: World Report on Disability. Geneva, World Health Organization, 2011.
21.
Posner BM, Jette AM, Smith KW, Miller DR: Nutrition and health risks in the elderly: the nutrition screening initiative. Am J Public Health 1993;83:972-978.
22.
Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K: Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci 2010;65A:377-381.
23.
Puts MTE, Lips P, Deeg DJH: Sex differences in the risk of frailty for mortality independent of disability and chronic diseases. J Am Geriatr Soc 2005;53:40-47.
24.
Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP: The association between obesity and the frailty syndrome in older women: the women's health and aging studies. J Am Geriatr Soc 2005;53:927-934.
25.
Kulminski AM, Arbeev KG, Kulminskaya IV, Ukraintseva SV, Land K, Akushevich I, Yashin AI: Body mass index and nine-year mortality in disabled and nondisabled U.S. older individuals. J Am Geriatr Soc 2008;56:105-110.
26.
Walter S, Kunst A, Mackenbach J, Hofman A, Tiemeier H: Mortality and disability: the effect of overweight and obesity. Int J Obes 2009;33:1410-1418.
27.
Schooling CM, Lam TH, Li ZB, Ho SY, Chan WM, Ho KS, Tham MK, Cowling BJ, Leung GM: Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006;166:1498-1504.
28.
Jee SH, Sull JW, Park J, Lee S-Y, Ohrr H, Guallar E, Samet JM: Body-mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-787.
29.
Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L: Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008;11:693-700.
30.
Halanych JH, Shuaib F, Parmar G, Tanikella R, Howard VJ, Roth DL, Prineas RJ, Safford MM: Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Epidemiol 2011;173:1319-1326.
31.
Klinkenberg M, Smit JH, Deeg DJH, Willems DL, Onwuteaka-Philipsen BD, van der Wal G: Proxy reporting in after-death interviews: the use of proxy respondents in retrospective assessment of chronic diseases and symptom burden in the terminal phase of life. Palliat Med 2003;17:191-201.
32.
Iannuzzi-Sucich M, Prestwood KM, Kenny AM: Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002;57:M772-M777.
33.
Chang S-H, Beason TS, Hunleth JM, Colditz GA: A systematic review of body fat distribution and mortality in older people. Maturitas 2012;72:175-191.
34.
Rockwood K, Andrew M, Mitnitski A: A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 2007;62:738-743.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.